2m 2m 2m 2m 2m 2m 2m
RAPPORT THERA (RAPP)
NASDAQ
$38.50-$0.38 (-0.97%)
Price as of Jun 23, 2026 7:56 PM EDT- $1.8BMarket Cap
- 214.05%1-Year Change
- BiotechnologyIndustry
RAPPORT THERA (RAPP)
$38.50-$0.38 (-0.97%)
RAPP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $38.88 | ||
Change | +$0.69 (+1.81%) | ||
Open | $37.83 | ||
High | $39.45 | ||
Low | $37.08 | ||
Previous Close | $38.19 | ||
Volume | 206,199 | ||
30-Day Average Volume | 301,387 | ||
1-Week Change | 1.01% | ||
1-Month Change | 3.08% | ||
1-Year Change | 214.05% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 47.8M | ||
Total Assets | $497.6M | ||
Market Cap | $1.8B | ||
Enterprise Value | $1.7B | ||
Period: QTR TTM FY | |||
Revenue | $20.0M | ||
Net Income | -$19.9M | ||
Free Cash Flow | -$13.1M | ||
EBIT | -$19.9M | ||
EBITDA | -$19.6M | ||
Net Working Capital | $466.8M | ||
EPS | -$0.42 | ||
Enterprise Value/EBITDA | -89 | ||
Enterprise Value/Revenue | 87 | ||
P/B | 4 | ||
P/E | -91 | ||
PEG | -2 | ||
Price/Free Cash Flow | -139 | ||
Price/Operating Cash Flow | -140 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue